Categories News Press Releases Archives 2025 August July June May April March February January 2024 December November October September August July June May April March February January 2023 December November October September August July June April March February January 2022 December November October September August June May March February January 2021 December November October September August May April February Aug 07 New Two-Year Data Showed Bimekizumab Maintained High Levels of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis Read More Share:| | | Apr 28 UCB Announces PDUFA Date for Bimekizumab Read More Share:| | | Apr 23 "The New England Journal of Medicine" Publishes Results from Two Bimekizumab Phase 3 Studies in Moderate to Severe Plaque Psoriasis Read More Share:| | | Apr 23 UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021 UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021 Read More Share:| | | Feb 23 UCB and Microsoft Expand Collaboration to Accelerate Drug Discovery and Development Read More Share:| | | Feb 05 The Lancet Publishes Two Phase 3 Studies Detailing Bimekizumab Data in Moderate to Severe Plaque Psoriasis Read More Share:| | | Pagination First page Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Current page 9